Michael A. Bolognese
0000-0002-7102-5518
Publication & Citation Trends
Most Cited Works
Publications
106 total
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
Cited by 459
OpenAlex
The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group PDF
Cited by 652
OpenAlex
A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density PDF
Cited by 291
OpenAlex
Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 as monotherapy in patients with hypercholesterolaemia (MENDEL): a randomised, double-blind, placebo-controlled, phase 2 study
Cited by 360
OpenAlex
Effects of Denosumab Treatment and Discontinuation on Bone Mineral Density and Bone Turnover Markers in Postmenopausal Women with Low Bone Mass
Cited by 605
OpenAlex
Research Topics
Bone health and osteoporosis research
(70)
Bone health and treatments
(59)
Bone Metabolism and Diseases
(38)
Lipoproteins and Cardiovascular Health
(13)
Bone and Joint Diseases
(13)
Frequent Co-Authors
Affiliations
Western University
Oslo University Hospital
Brigham and Women's Hospital
Lawson Health Research Institute
Amgen (United States)